Mateon Therapeutics Inc (OTCQX US:MATN.PK)

0.229
Delayed Data
As of 10:59am ET
 +0.0092 / +4.19%
Today’s Change
0.09
Today|||52-Week Range
0.65
+55.89%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization2.0K2.0K2.0K2.0K
 
 
 
 
 
 
Operating ExpensesGross Income-2.0K-2.0K-2.0K-2.0K
 
 
 
 
 
General Expenses3.9M3.5M2.4M793.0K
 
 
 
 
 
Research And Development3.0M2.8M1.8M225.0K
 
 
 
 
 
Total Operating Expenses3.9M3.5M2.4M795.0K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.9M-3.5M-2.4M-795.0K
 
 
 
 
 
Other Expenses0.00-3.0K0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.9M-3.5M-2.4M-794.0K
 
 
 
 
 
Net Income-3.9M-3.5M-2.4M-794.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS26.5M26.5M26.5M26.5M
 
 
 
 
 
Shares To Calculate EPS Diluted26.5M26.5M26.5M26.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.15-$0.13-$0.09-$0.03
 
 
 
 
 
EPS Diluted-$0.15-$0.13-$0.09-$0.03